NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/01/2024
Voltar para busca
Dado oficial do USPTO
TAGWORKS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
09/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
09/08/2021
Data de registro
09/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/01/2024
Última transação
09/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Nijmegen, NL
Examinador
ALTREE, NICK
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Tagworks Pharmaceuticals BV
Representantes
Michael Fedrick LOZA & LOZA, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemical preparations for use in industry and science; chemical preparations and kits comprised of chemical preparationsfor use in modifying or isolating biological materials; chemical preparations for solid phase chemistry or separation technologysuch as coated polymersin bead or resin formfor use in manufacturing
Classe 5
pharmaceutical and veterinary preparationsT-cell engaging biologics or drug conjugates based on biologics for therapybiologics for immunoimagingimmunotherapy; pharmaceutical and veterinary preparationsantibodiesantibody fragmentspeptides or small molecules for immunotherapy treatment; pharmaceutical and veterinary nanoparticlespolymersliposomesantibodies modified with a chemical tag or a radiolabeled chemical tagfor nuclear imaging or therapy; pharmaceutical preparations for treatment or prevention of cancerautoimmune or infectious disease; pharmaceutical and chemical preparations for medical purposeschemical probes or chemical tags conjugated to biologics for the treatment of cancerautoimmune diseaseinfectious disease; sanitary preparations for medical purposes; biopharmaceutical preparations for use in human and veterinary medicine for treatment of cancerautoimmune diseases and infectious diseases; diagnostic preparations for medical purposes; chemical reagents for medical and veterinary purposes; chemicals and biological substances for medical usediagnostic reagents; pharmaceutical and veterinary preparationsimmune cell engaging biologicspreparations for imagingprodrugsdrug conjugates based on biologics for therapybiologicspeptides or small molecules for radiotherapyimmunotherapy or chemotherapy; pharmaceutical and veterinary nanoparticlespolymersliposomesbiologicspeptidessmall molecules modified with a chemical tag or linker or a radiolabelled chemical tagfor nuclear imaging or therapy; pharmaceutical and chemical preparations for medical purposeschemical probes or chemical tags or linkers conjugated to biologics for the treatment of cancerautoimmune diseaseinfectious disease
Classe 42
scientific and technological research in the field of immunoimaging and immunotherapy to provide T-cell engaging biologics or preparations for imaging or drug conjugates based on antibodiesantibody fragmentspeptidesnanoparticle polymers or nanoparticle liposomesradiolabeled antibodies for nuclear imaging or therapyto provide preparations for medical diagnostics; scientific and technological researchin the field of imaging or immunotherapy to provide immune-cell engaging biologics or preparations for imaging or drug conjugates based on biologics for therapyantibodiesantibody fragmentspeptidessmall moleculesnanoparticle polymers or nanoparticle liposomesradiolabelled antibodiesbiologicspeptides and small molecules for nuclear imaging or therapyto provide preparations for medical diagnostics
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
04/12/2023
NOAC
CORRECTED NOA E-MAILED
19/09/2023
ICNA
NOTICE OF ALLOWANCE CORRECTION ENTERED
18/09/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
23/08/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
23/08/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/08/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/06/2023
INOA
AMENDMENT AFTER NOA NOT ENTERED
16/06/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
16/06/2023
EX1G
SOU EXTENSION 1 GRANTED
16/06/2023
EXT1
SOU EXTENSION 1 FILED
16/06/2023
EEXT
SOU TEAS EXTENSION RECEIVED
16/06/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2022
PUBO
PUBLISHED FOR OPPOSITION
08/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/05/2022
GNRT
NON-FINAL ACTION E-MAILED
11/05/2022
CNRT
NON-FINAL ACTION WRITTEN
11/05/2022
DOCK
ASSIGNED TO EXAMINER
07/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/10/2021
NWAP
NEW APPLICATION ENTERED
12/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TAGWORKS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.